Whole-body diffusion-weighted imaging for staging malignant lymphoma in children

[1]  Peter R Luijten,et al.  ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. , 2010, European journal of radiology.

[2]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[3]  Ernst J Rummeny,et al.  Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. , 2009, European journal of radiology.

[4]  T. Takahara,et al.  Whole-Body MRI, Including Diffusion-Weighted Imaging, for the Initial Staging of Malignant Lymphoma: Comparison to Computed Tomography , 2009, Investigative radiology.

[5]  I. Steffen,et al.  Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  K. Chida,et al.  Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. , 2009, Radiology.

[7]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[8]  Maria Triantafyllou,et al.  Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. , 2009, European urology.

[9]  L. Quekel,et al.  CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. , 2009, AJR. American journal of roentgenology.

[10]  C. Kuhl,et al.  Parallel RF transmission in body MRI for reduced dielectric shading, improved B1 homogeneity and accelerated imaging at 3.0T: Initial clinical experience in 40 patients using MultiTransmit , 2009 .

[11]  T. Laor,et al.  MR imaging insights into skeletal maturation: what is normal? , 2009, Radiology.

[12]  H. Schlemmer,et al.  A look ahead: PET/MR versus PET/CT , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  T. Takahara,et al.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer , 2009, European Radiology.

[14]  Nikolaus Weiskopf,et al.  Efficient fat suppression by slice-selection gradient reversal in twice-refocused diffusion encoding , 2008, Magnetic resonance in medicine.

[15]  Y. Kitazume,et al.  Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? , 2008, AJR. American journal of roentgenology.

[16]  Timothy D Johnson,et al.  Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  L. Terracciano,et al.  Patterns of liver infiltration in lymphoproliferative disease , 2008, Histopathology.

[18]  Peter R. Luijten,et al.  Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology , 2008, European Radiology.

[19]  T. Kwee,et al.  Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma , 2008, British journal of haematology.

[20]  S. Shiraishi,et al.  Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  E. Hecht,et al.  Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. , 2008, Radiology.

[22]  Thomas C Kwee,et al.  Imaging in staging of malignant lymphoma: a systematic review. , 2008, Blood.

[23]  T. Nihashi,et al.  18F-FDG PET for Posttherapy Assessment of Hodgkin's Disease and Aggressive Non-Hodgkin's Lymphoma: A Systematic Review , 2007, Journal of Nuclear Medicine.

[24]  W. Mali,et al.  Fat suppression with Slice-Selection Gradient Reversal (SSGR) revisited; , 2008 .

[25]  D. Yeung,et al.  Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. , 2007, Radiology.

[26]  D. Brenner,et al.  Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.

[27]  T. Gross,et al.  Pediatric non-Hodgkin’s lymphoma , 2007, Current oncology reports.

[28]  B. Ross,et al.  Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  H. Schild,et al.  Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla , 2007, European Radiology.

[30]  M. Hudson,et al.  Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity. , 2007, Seminars in radiation oncology.

[31]  W. Huda,et al.  Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI , 2007, Journal of magnetic resonance imaging : JMRI.

[32]  Klemens Scheidhauer,et al.  Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  Andrew C Larson,et al.  Multishot Diffusion-Weighted PROPELLER Magnetic Resonance Imaging of the Abdomen , 2006, Investigative radiology.

[34]  M. Van Cauteren,et al.  MR microimaging of benign and malignant nodes in the neck. , 2006, AJR. American journal of roentgenology.

[35]  A. Darzi,et al.  Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. , 2006, The Lancet Oncology.

[36]  Lotty Hooft,et al.  18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review. , 2006, Haematologica.

[37]  A. A. Abdel Razek,et al.  Role of diffusion-weighted MR imaging in cervical lymphadenopathy , 2006, European Radiology.

[38]  H. Kawai,et al.  Diffusion-weighted imaging of the liver: technical challenges and prospects for the future. , 2005, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[39]  S. Schoenberg,et al.  High-Resolution Whole-Body Magnetic Resonance Image Tumor Staging With the Use of Parallel Imaging Versus Dual-Modality Positron Emission Tomography–Computed Tomography: Experience on a 32-Channel System , 2005, Investigative radiology.

[40]  J. Armitage,et al.  Staging Non‐Hodgkin Lymphoma , 2005, CA: a cancer journal for clinicians.

[41]  I. Pedrosa,et al.  Lymphoplasmacytic sclerosing pancreatitis. , 2005, AJR. American journal of roentgenology.

[42]  J. Connors,et al.  State-of-the-art therapeutics: Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  S. Eustace,et al.  A comparison of whole-body MRI and CT for the staging of lymphoma. , 2005, AJR. American journal of roentgenology.

[44]  J. Ioannidis,et al.  18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  Fritz Schick,et al.  Whole-body MRI at high field: technical limits and clinical potential , 2005, European Radiology.

[46]  E. Steliarova-Foucher,et al.  Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study , 2004, The Lancet.

[47]  P. Babyn,et al.  Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children , 2004, European Radiology.

[48]  P. Babyn,et al.  Fast STIR whole-body MR imaging in children. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[49]  T. Takahara,et al.  Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. , 2004, Radiation medicine.

[50]  K. Hayashi,et al.  Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. , 2003, AJNR. American journal of neuroradiology.

[51]  Whole-body turbo STIR MR imaging: controversies and avenues for development , 2003, European Radiology.

[52]  H. Shibuya,et al.  MR detection of iliac bone marrow involvement by malignant lymphoma with various MR sequences including diffusion-weighted echo-planar imaging , 2002, Skeletal Radiology.

[53]  T. Akashi,et al.  Relationship between bone marrow cellularity and apparent diffusion coefficient , 2001, Journal of magnetic resonance imaging : JMRI.

[54]  D. Norris.  Implications of bulk motion for diffusion‐weighted imaging experiments: Effects, mechanisms, and solutions , 2001, Journal of magnetic resonance imaging : JMRI.

[55]  R. Gonzalez,et al.  Diffusion-weighted MR imaging of the brain. , 2000, Radiology.

[56]  R. Walker,et al.  Turbo STIR magnetic resonance imaging as a whole‐body screening tool for metastases in patients with breast carcinoma: Preliminary clinical experience , 2000, Journal of magnetic resonance imaging : JMRI.

[57]  P. Boesiger,et al.  SENSE: Sensitivity encoding for fast MRI , 1999, Magnetic resonance in medicine.

[58]  G. Jerusalem,et al.  Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. , 1999, Blood.

[59]  G. Johnson,et al.  Fat suppression in MR imaging: techniques and pitfalls. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[60]  I. Fogelman,et al.  Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. , 1996, Seminars in nuclear medicine.

[61]  A. Polliack,et al.  Pulmonary involvement in lymphoma. , 1993, Leukemia & lymphoma.

[62]  J. Tsuruda,et al.  Cytotoxic brain edema: assessment with diffusion-weighted MR imaging. , 1992, Radiology.

[63]  R Weissleder,et al.  Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. , 1991, Radiology.

[64]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. , 1990, Radiology.

[65]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[66]  D. Fairclough,et al.  Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[68]  D Crowther,et al.  The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  Murphy Sb.  Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. , 1980 .

[70]  S. Murphy.  Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. , 1980, Seminars in oncology.

[71]  J. E. Tanner,et al.  Spin diffusion measurements : spin echoes in the presence of a time-dependent field gradient , 1965 .